(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.08%) $79.06
(5.02%) $2.03
(0.10%) $2 313.40
(0.68%) $26.93
(0.85%) $963.00
(-0.07%) $0.932
(-0.26%) $11.00
(-0.05%) $0.798
(-1.37%) $91.99
Live Chart Being Loaded With Signals
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States...
Stats | |
---|---|
Today's Volume | 32 741.00 |
Average Volume | 32 319.00 |
Market Cap | 9.80M |
EPS | $0 ( 2023-08-29 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -14.82 |
ATR14 | $0.0260 (1.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2004-08-24 | Patou Gary | Sell | 2 500 | Stock Options |
2004-08-25 | Patou Gary | Sell | 5 500 | Stock Options |
2004-07-01 | Hennessey Robert J | Sell | 1 500 | Stock Options |
2004-06-29 | Kirby Pamela J | Buy | 9 047 | Stock Options(right to buy) |
2004-06-29 | Kirby Pamela J | Buy | 25 000 | Stock Options(right to buy) |
INSIDER POWER |
---|
0.00 |
Last 92 transactions |
Buy: 380 693 | Sell: 1 344 573 |
Volume Correlation
Genetic Technologies Ltd Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Genetic Technologies Ltd Correlation - Currency/Commodity
Genetic Technologies Ltd Financials
Annual | 2023 |
Revenue: | $8.69M |
Gross Profit: | $4.35M (50.09 %) |
EPS: | $-0.120 |
FY | 2023 |
Revenue: | $8.69M |
Gross Profit: | $4.35M (50.09 %) |
EPS: | $-0.120 |
FY | 2022 |
Revenue: | $6.79M |
Gross Profit: | $6.47M (95.27 %) |
EPS: | $-0.0773 |
FY | 2021 |
Revenue: | $120 554 |
Gross Profit: | $-240 473 (-199.47 %) |
EPS: | $-48.00 |
Financial Reports:
No articles found.
Genetic Technologies Ltd
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators